The effect of rebamipide for healthy subjects with nonsteroidal anti-inflammatory drug (NSAID)-induced small intestinal injury: a prospective, randomised, double-blinded, placebo-controlled study.

Trial Profile

The effect of rebamipide for healthy subjects with nonsteroidal anti-inflammatory drug (NSAID)-induced small intestinal injury: a prospective, randomised, double-blinded, placebo-controlled study.

Completed
Phase of Trial: Phase III

Latest Information Update: 29 Apr 2011

At a glance

  • Drugs Rebamipide (Primary)
  • Indications NSAID-induced gastrointestinal damage
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Apr 2011 Status changed from active, no longer recruiting to completed as reported by ISRCTN.
    • 23 Aug 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top